?

Sahni Payal

Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK 1817124

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
346,040,000
Price per Share :
$26.49
Equivalence :
$9,166,599,600.00

Transaction History

  • M
    Form 4
    346,040,000 Shares After Transaction
    Value : $9,460,733,600.00
    $3,151,481,800.00
    02/23/24
  • Footnotes:
    #1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
    #2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
    #3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
    #4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • F
    Form 4
    336,990,000 Shares After Transaction
    Value : $9,354,842,400.00
    $251,228,000.00
    02/23/24
  • F
    Form 4
    243,850,000 Shares After Transaction
    Value : $6,674,174,500.00
    $2,549,241,800.00
    02/23/24